Ultrasonic Interfacial Engineering of MoS₂‐Modified Zn Single‐Atom Catalysts for Efficient Osteomyelitis Sonodynamic Ion Therapy

for 28 days within safe concentration, realizing the great osteoinductive ability of such a sonosensitizer. For the treatment of MRSA-infected osteomyelitis, the inflammation and bone loss can be significantly suppressed through sonodynamic ion therapy. This work provides another strategy for developing high efficiency sonosensitizer through ultrasound interfacial engineering.